Stock Market & Financial Investment News

News Breaks December 28, 2012 07:05 EDT RNN Rexahn initiated with an Outperform at Burrill Target $1.00. Burrill believes Rexahn’s pipeline in oncology and CNS disorders is undervalued. News For RNN From The Last 14 Days Check below for free stories on RNN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for RNN Sign up for a free trial to see the rest of the stories you've been missing.